Circulating Plasminogen Concentration at Admission in Patients with Coronavirus Disease 2019 (COVID-19)

Este es el reporte de situación COVID-19 Colombia No 135 - 03 de septiembre de 2020

[1]  Y. Li,et al.  Plasminogen improves lung lesions and hypoxemia in patients with COVID-19 , 2020, QJM : monthly journal of the Association of Physicians.

[2]  D. Collen.  Molecular mechanisms of fibrinolysis and their application to fibrin‐specific thrombolytic therapy , 1987, Journal of cellular biochemistry.

[3]  S. Matalon,et al.  Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility , 2020, Physiological reviews.

[4]  C. Wohlford-Lenane,et al.  Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg9 bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration. , 2018, American journal of physiology. Lung cellular and molecular physiology.

[5]  R. Aisina.  Structure and functions of the plasminogen/plasmin system , 2015 .

[6]  Mario Plebani,et al.  Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis , 2020, Clinical chemistry and laboratory medicine.

[7]  G. Lippi,et al.  COVID-19: unravelling the clinical progression of nature’s virtually perfect biological weapon , 2020, Annals of translational medicine.

[8]  R. McIntyre,et al.  Tissue plasminogen activator (tPA) treatment for COVID‐19 associated acute respiratory distress syndrome (ARDS): A case series , 2020, Journal of Thrombosis and Haemostasis.

[9]  G. Lippi,et al.  D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis , 2020, Thrombosis and Haemostasis.

[10]  R. McIntyre,et al.  Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection , 2020, Journal of the American College of Surgeons.

[11]  G. Lippi,et al.  Hypertension and its severity or mortality in Coronavirus Disease 2019 (COVID-19): a pooled analysis. , 2020, Polish archives of internal medicine.

[12]  T. Martin,et al.  Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. , 1989, The Journal of clinical investigation.

[13]  L. Miles,et al.  Plasminogen Receptors: The First Quarter Century , 2013, Seminars in Thrombosis & Hemostasis.

[14]  G. Lippi,et al.  Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis , 2020, Current Problems in Cardiology.

[15]  H. Kwaan.  Coronavirus Disease 2019: The Role of the Fibrinolytic System from Transmission to Organ Injury and Sequelae , 2020, Seminars in Thrombosis and Hemostasis.

[16]  H. Krumholz,et al.  Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research , 2020, Thrombosis and Haemostasis.

[17]  C. Ruppert,et al.  Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. , 2000, American journal of respiratory and critical care medicine.

[18]  G. Lippi,et al.  Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19) , 2020, Respiratory Medicine.

[19]  E. Verna,et al.  Acute Liver Injury in COVID‐19: Prevalence and Association with Clinical Outcomes in a Large U.S. Cohort , 2020, Hepatology.

[20]  Giuseppe Lippi,et al.  Coronavirus disease 2019 (COVID-19): the portrait of a perfect storm , 2020, Annals of translational medicine.

[21]  Giuseppe Lippi,et al.  Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis , 2020, Clinica Chimica Acta.

[22]  D. Vaughan,et al.  Bradykinin Stimulates Tissue Plasminogen Activator Release From Human Forearm Vasculature Through B2 Receptor–Dependent, NO Synthase–Independent, and Cyclooxygenase-Independent Pathway , 2000, Circulation.

[23]  G. Lippi,et al.  Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection , 2020, International Urology and Nephrology.

[24]  G. Lippi,et al.  Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature , 2020, International journal of stroke : official journal of the International Stroke Society.